Cbd Life Sciences Inc (CBDL)
Featured in
Overvalued Stocks
CBD Life Sciences Inc. is a common stock listing on OTC Markets. The company develops and markets cannabidiol-based organic products, with offerings that include hemp drops, massage oils, recovery pain relief creams, supplements aimed at anxiety and sleep support, edibles, coffee, wine, skincare products, tablets, and pet products. The company was formerly known as Optium Cyber Systems, Inc., and adopted its current name in January 2019. CBD Life Sciences Inc. is based in Scottsdale, Arizona.
Stock Summary
Fair Value
Profitability & Growth
Quality & Risk
Events & Dividends
Technical Outlook
FAQ
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
Data update note:
Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
OTC-CBDL
|
$0.00020
|
-33.3% Downside
|
Overvalued
|
—
|
—
|
—
|
Fair
|
—
|
—
|
—
|
0.0%
|
August 18, 2026
|
-12.1x
|
0.9x
|
6.0x
|
1.483 M
|
227.683 K
|
0.0%
|
—
|
-3.0
|
—
|
284.4%
|
